Concepts (65)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pneumopericardium | 1 | 2019 | 4 | 0.680 |
Why?
|
| Hypoxia-Ischemia, Brain | 3 | 2006 | 154 | 0.620 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2019 | 641 | 0.410 |
Why?
|
| Cerebral Palsy | 2 | 2003 | 86 | 0.390 |
Why?
|
| Chemoprevention | 1 | 2008 | 251 | 0.280 |
Why?
|
| Cystic Fibrosis | 1 | 2008 | 294 | 0.250 |
Why?
|
| Hypothermia, Induced | 1 | 2006 | 179 | 0.240 |
Why?
|
| Fetal Distress | 1 | 2003 | 12 | 0.230 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2008 | 444 | 0.230 |
Why?
|
| Infant, Newborn | 8 | 2019 | 8699 | 0.200 |
Why?
|
| Antiviral Agents | 1 | 2008 | 1253 | 0.180 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2002 | 182 | 0.170 |
Why?
|
| Learning | 1 | 2002 | 431 | 0.160 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2002 | 347 | 0.150 |
Why?
|
| Antibodies, Monoclonal | 1 | 2008 | 4481 | 0.120 |
Why?
|
| Palivizumab | 1 | 2008 | 62 | 0.080 |
Why?
|
| Term Birth | 1 | 2006 | 34 | 0.070 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2006 | 600 | 0.060 |
Why?
|
| Acidosis | 1 | 2006 | 117 | 0.060 |
Why?
|
| Fetal Blood | 1 | 2006 | 501 | 0.050 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2005 | 188 | 0.050 |
Why?
|
| Sex Distribution | 1 | 2003 | 497 | 0.050 |
Why?
|
| Neonatology | 1 | 2002 | 50 | 0.050 |
Why?
|
| Deafness | 1 | 2002 | 91 | 0.050 |
Why?
|
| Pregnancy | 2 | 2006 | 8130 | 0.050 |
Why?
|
| Infant, Premature | 1 | 2005 | 844 | 0.040 |
Why?
|
| Fetal Diseases | 1 | 2003 | 456 | 0.040 |
Why?
|
| Risk Factors | 3 | 2006 | 17888 | 0.040 |
Why?
|
| Hospitalization | 1 | 2008 | 2167 | 0.040 |
Why?
|
| Humans | 8 | 2019 | 270740 | 0.040 |
Why?
|
| Male | 4 | 2019 | 128315 | 0.040 |
Why?
|
| Emergency Medical Services | 1 | 2002 | 470 | 0.040 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2008 | 3409 | 0.030 |
Why?
|
| Heart Defects, Congenital | 1 | 2005 | 1795 | 0.030 |
Why?
|
| Incidence | 1 | 2003 | 5824 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2003 | 4372 | 0.030 |
Why?
|
| Infant | 1 | 2008 | 13999 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2003 | 9292 | 0.020 |
Why?
|
| Female | 4 | 2008 | 148940 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2002 | 6764 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2002 | 3187 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2002 | 5776 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2003 | 15218 | 0.020 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2005 | 171 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 2002 | 330 | 0.010 |
Why?
|
| Mutation | 1 | 2002 | 15912 | 0.010 |
Why?
|
| Respiration, Artificial | 1 | 2005 | 585 | 0.010 |
Why?
|
| Aminoglycosides | 1 | 2002 | 233 | 0.010 |
Why?
|
| Postoperative Care | 1 | 2005 | 728 | 0.010 |
Why?
|
| Animals | 1 | 2006 | 61956 | 0.010 |
Why?
|
| Neonatal Screening | 1 | 2002 | 188 | 0.010 |
Why?
|
| Reoperation | 1 | 2005 | 1392 | 0.010 |
Why?
|
| DNA Primers | 1 | 2002 | 1496 | 0.010 |
Why?
|
| Haplotypes | 1 | 2002 | 910 | 0.010 |
Why?
|
| Preoperative Care | 1 | 2005 | 1567 | 0.010 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2005 | 1158 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2002 | 2357 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2002 | 3476 | 0.010 |
Why?
|
| Alleles | 1 | 2002 | 2600 | 0.010 |
Why?
|
| DNA | 1 | 2002 | 3050 | 0.010 |
Why?
|
| Palliative Care | 1 | 2005 | 2178 | 0.010 |
Why?
|
| Survival Rate | 1 | 2005 | 12541 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2005 | 5681 | 0.010 |
Why?
|
| United States | 1 | 2002 | 15861 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2005 | 33737 | 0.000 |
Why?
|